VolitionRx (VNRX) SEC Filings & 10K Form

$0.74
+0.02 (+2.22%)
(As of 05:27 PM ET)

Recent VolitionRx SEC Filings

DateFilerForm TypeView
05/03/2024
3:07 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
10:14 AM
VolitionRx (Filer)
Form D
Notice of Exempt Offering of Securities 
03/25/2024
3:19 PM
VolitionRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
3:37 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:01 PM
Futcher Edward (Reporting)
VolitionRx (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Colman Alan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Batchelor Ann-Louise (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Hughes Terig (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Barnes Phillip (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
9:41 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:00 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
9:59 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
8:38 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
8:11 AM
Rootsaert Rodney Gerard (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
7:51 AM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:07 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
8:39 AM
Futcher Edward (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
8:39 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
9:28 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
10:06 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
9:01 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:16 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:02 PM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
3:05 PM
Hughes Terig (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Forterre Gael (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Michel Gaetan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Faulkes Martin Charles (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:06 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
9:01 AM
Barnes Phillip (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
8:41 AM
Faulkes Martin Charles (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2023
8:35 AM
Micallef Jacob Vincent (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
9:07 AM
Micallef Jacob Vincent (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
10:49 AM
Futcher Edward (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
10:49 AM
Kway Jasmine (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
11:00 AM
Michel Gaetan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:40 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
11:28 AM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The new financial threat that could wipe out millions… (Ad)

During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.

Pay close attention to this important video
08/14/2023
3:31 PM
VolitionRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
3:18 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:57 PM
VolitionRx (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2023
9:14 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
8:56 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:56 PM
VolitionRx (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:VNRX) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners